1-3 of 3
Jianliang Shen
Close
Sort by
Journal Articles

Chidamide, Decitabine, Cytarabine, Aclarubicin, and Granulocyte Colony-Stimulating Factor (CDCAG) in Adults with Relapsed/Refractory Acute Myeloid Leukemia: Final Results from a Phase 1/2 Study

Lixin Wang, PhD MD, Guofeng Chen, MD, Jianliang Shen, MD PhD, Jianmin Luo, Meiyun Fang, MD, Xudong Wei, MD, Yinghua Li, MD, Zhuogang Liu, MD, Yin Zhang, MD, Sujun Gao, PhD, Xin Wang, MD PhD, Xiaoning Gao, MD PhD, Wei Zhou, MD, Yigai Ma, MD, Hui Liu, MD, Xinquan Li, MD PhD, Linhua Yang, MD, Li Yu, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2707.
https://doi.org/10.1182/blood-2018-99-111761
Published: 2018
Journal Articles

Multicenter study of combination DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis

Clinical Trials & Observations
Yini Wang, Wenqiu Huang, Liangding Hu, Xinan Cen, Lihong Li, Jijun Wang, Jianliang Shen, Na Wei, Zhao Wang
Journal: Blood
Blood (2015) 126 (19): 2186–2192.
https://doi.org/10.1182/blood-2015-05-644914
Published: 2015
Journal Articles

Multi-Center Study of DEP Regimen As a Salvage Therapy for Adult Refractory Hemophagocytic Lymphohistiocytosis

Yini Wang, MD, Zhao Wang, MD, Wenqiu Huang, Liangding Hu, Xinan Cen, Lihong Li, Jijun Wang, Jianliang Shen, Na Wei
Journal: Blood
Blood (2014) 124 (21): 2748.
https://doi.org/10.1182/blood.V124.21.2748.2748
Published: 2014